Sartorius Stedim Biotech
5 Orville Drive, Bohemia, NY 11716
Contact:
PH: (800) 368-7178
FX: (631) 254-4253
www.sartorius-stedim.com
Company Description:
Sartorius Stedim Biotech is a leading provider of cutting edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management, and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely, and economically. For the next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific research community, and closely allied with customers and technology partners, the company is dedicated to its philosophy of “turning science into solutions” on a daily basis.
Sartoguard®0.1 and 0.2µm nominal Prefilters
Sartorius Stedim Biotech is the first major filter supplier to launch two new unique Integrity Testable, bacterially retentive to LRV=6/cm2 Prefilters: Sartoguard®PES/GF 0.1 and 0.2 µm nominal. They combine excellent clarification capabilities of GF layers with exceptional throughput performance of PES membranes. Sartoguard® offers significant performance benefits in many Biopharmaceutical applications including Media Prefiltration, turbidity/aggregates removal in DSP; and Bioburden reduction in Cell Harvest/Downstream Intermediates. Please visit us at INTERPHEX at Booth #2805 or at www.sartorius.com/sartoguard to learn more.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.